Live Breaking News & Updates on Metagenomi Company Profile

Stay updated with breaking news from Metagenomi company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Metagenomi's (MGX) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $10.00 price objective on the stock. HC Wainwright also issued estimates for Metagenomi’s Q2 2024 earnings at ($0.69) EPS, Q3 2024 earnings at ($0.71) […] ....

United States , Vanguard Group Inc , Wells Fargo Company , Jefferies Financial Group , Metagenomi Company Profile , Hhlr Advisors , Jpmorgan Chase Co , Artal Group , Altitude Crest Partners Inc , Metagenomi Inc , Free Report , Moderate Buy , Altitude Crest Partners , Get Free Report , Metagenomi Daily ,

Metagenomi, Inc. (NASDAQ:MGX) Receives Average Recommendation of "Buy" from Analysts

Metagenomi, Inc. (NASDAQ:MGX) Receives Average Recommendation of "Buy" from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Metagenomi Company Profile , Securities Exchange Commission , Wells Fargo Company , Holdingsas Novo , Jpmorgan Chase Co , Jefferies Financial Group , Metagenomi Inc , Get Free Report , Financial Group , Chardan Capital , Exchange Commission , Get Free , Metagenomi Daily ,

Brokerages Set Metagenomi, Inc. (NASDAQ:MGX) Price Target at $21.40

Metagenomi, Inc. (NASDAQ:MGX – Get Free Report) has earned an average rating of “Buy” from the six ratings firms that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have covered the stock in the last year is $21.40. […] ....

United States , Jpmorgan Chase Co , Metagenomi Inc , Holdingsas Novo , Wells Fargo Company , Metagenomi Company Profile , Get Free Report , Trading Down , Get Free , Metagenomi Daily , Nasdaq Mgx ,

Metagenomi (NASDAQ:MGX) Now Covered by Analysts at Wells Fargo & Company

Wells Fargo & Company started coverage on shares of Metagenomi (NASDAQ:MGX – Free Report) in a report released on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $25.00 target price on the stock. Metagenomi Price Performance MGX stock opened at $11.78 on Tuesday. Metagenomi has a 12-month low of $9.74 and […] ....

United States , Metagenomi Inc , Holdingsas Novo , Securities Exchange Commission , Wells Fargo Company , Metagenomi Company Profile , Wells Fargo , Free Report , Exchange Commission , Get Free Report , Metagenomi Daily ,

Metagenomi (NASDAQ:MGX) Coverage Initiated by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. initiated coverage on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $16.00 price target on the stock. MGX has been the topic of several other research reports. Jefferies Financial Group started coverage on […] ....

United States , Jefferies Financial Group , Metagenomi Inc , Securities Exchange Commission , Wells Fargo Company , Metagenomi Company Profile , Holdingsas Novo , Jpmorgan Chase Co , Free Report , Financial Group , Chardan Capital , Stock Down , Exchange Commission , Get Free Report , Metagenomi Daily ,